Newsfiscal.ai
NovaBridge Biosciences Appoints Chuck Silberstein as Chief Financial Officer
· Published
Article summary
NovaBridge Biosciences has named Dr. Chuck Silberstein as its new Chief Financial Officer, effective November 2, 2026, succeeding Kyler Lei.
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…